Your browser doesn't support javascript.
loading
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.
Stolbrink, M; Chinouya, M J; Jayasooriya, S; Nightingale, R; Evans-Hill, L; Allan, K; Allen, H; Balen, J; Beacon, T; Bissell, K; Chakaya, J; Chiang, C-Y; Cohen, M; Devereux, G; El Sony, A; Halpin, D M G; Hurst, J R; Kiprop, C; Lawson, A; Macé, C; Makhanu, A; Makokha, P; Masekela, R; Meme, H; Khoo, E M; Nantanda, R; Pasternak, S; Perrin, C; Reddel, H; Rylance, S; Schweikert, P; Were, C; Williams, S; Winders, T; Yorgancioglu, A; Marks, G B; Mortimer, K.
Affiliation
  • Stolbrink M; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Stellenbosch University, Tygerberg, South Africa.
  • Chinouya MJ; Education Department, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Jayasooriya S; Academic Unit of Primary Care, University of Sheffield, Sheffield, UK.
  • Nightingale R; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, IcFEM Dreamland Mission Hospital, Kimilili, Kenya.
  • Evans-Hill L; Nifty Fox Creative, Sheffield, UK.
  • Allan K; Healthcare Consultant, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, The Gambia.
  • Allen H; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, The Gambia.
  • Balen J; School of Health and Related Research, University of Sheffield, Sheffield, UK.
  • Beacon T; Medical Aid International, Bedford, UK.
  • Bissell K; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Chakaya J; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK, Department of Medicine, Therapeutics and Dermatology, Kenyatta University, Nairobi, Kenya.
  • Chiang CY; International Union Against Tuberculosis and Lung Disease, Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Med
  • Cohen M; Asociación Latinoamericana del Tórax, Forum of International Respiratory Societies, Guatemala.
  • Devereux G; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
  • El Sony A; The Epidemiological Laboratory (Epi-Lab) for Public Health, Research and Development, Khartoum Sudan.
  • Halpin DMG; University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK.
  • Hurst JR; UCL Respiratory, University College London, London, UK.
  • Kiprop C; IcFEM Dreamland Mission Hospital, Kimilili, Kenya.
  • Lawson A; AstraZeneca, Cambridge, UK.
  • Macé C; International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Makhanu A; IcFEM Dreamland Mission Hospital, Kimilili, Kenya.
  • Makokha P; IcFEM Dreamland Mission Hospital, Kimilili, Kenya.
  • Masekela R; Department of Paediatrics and Child Health, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.
  • Meme H; Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya.
  • Khoo EM; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, International Primary Care Respiratory Group, Larbert, Scotland, UK.
  • Nantanda R; Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Pasternak S; GlaxoSmithKline, Brentford, UK.
  • Perrin C; International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Reddel H; The Woolcock Institute of Medical Research, The University of Sydney, Sydney, NSW, Australia, Global Initiative for Asthma (GINA), Fontana, WI, USA.
  • Rylance S; Noncommunicable Diseases Department, World Health Organization, Geneva, Switzerland.
  • Schweikert P; AstraZeneca, Cambridge, UK.
  • Were C; GlaxoSmithKline, Brentford, UK.
  • Williams S; International Primary Care Respiratory Group, Larbert, Scotland, UK.
  • Winders T; Global Allergy & Airways Patient Platform, Vienna, Austria.
  • Yorgancioglu A; Department of Pulmonology, Celal Bayar University Medical Faculty, Manisa, Turkey, Global Alliance Against Chronic Respiratory Diseases, Geneva, Switzerland.
  • Marks GB; International Union Against Tuberculosis and Lung Disease, Paris, France, University of New South Wales, Sydney, NSW, Australia.
  • Mortimer K; International Union Against Tuberculosis and Lung Disease, Paris, France, University of Cambridge, Cambridge, UK.
Int J Tuberc Lung Dis ; 26(11): 1023-1032, 2022 Nov 01.
Article in En | MEDLINE | ID: mdl-36281039
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiration Disorders / Developing Countries Type of study: Qualitative_research Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiration Disorders / Developing Countries Type of study: Qualitative_research Aspects: Determinantes_sociais_saude Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2022 Document type: Article Affiliation country: